CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Morgan Stanley 22nd Annual Global Healthcare Conference
1x1 Investor Meetings: Friday, September 6, 2024
Location: New York, NY
Baird 2024 Global Healthcare Conference
Fireside Chat: Wednesday, September 11, 2024, at 7:55am ET
Location: New York, NY
Chardan’s 8th Annual Genetic Medicines Conference
Fireside Chat: Monday, September 30, 2024, at 4:30pm ET
Location: New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$1.32 |
| Daily Change: | 0.20 17.86 |
| Daily Volume: | 3,350,815 |
| Market Cap: | US$90.640M |
December 27, 2024 November 07, 2024 September 05, 2024 | |
UGE International develops, owns, and operates commercial and community solar projects in the United States and strategic markets abroad. Our distributed energy solutions deliver cheaper, cleaner energy to businesses and consumers...
CLICK TO LEARN MORE
Northstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORE